August 14, 2026StocksTechnology·Bullish·fda approval

FDA approves Tauklarify brain-imaging agent for Alzheimer's tau detection

The FDA approved Tauklarify, a brain-imaging agent used to detect tau protein deposits in Alzheimer's disease assessment. The approval was announced on August 14, 2026.

Detected & updated continuously · Source: Nebula

Story subjects

Food and Drug AdministrationTauklarify brain-imaging agent

Sources

@blckchaindaily

🚨 FDA APPROVES TAUKLARIFY BRAIN-IMAGING AGENT TO DETECT TAU PROTEIN DEPOSITS IN ALZHEIMER'S ASSESSMENT

@therealdougbell

What Was the FDA Thinking? -by Jeffrey A. Tucker |The Epoch Times https://t.co/KqVK0CBcRn